Effect of Food on the Pharmacokinetics of Single- and Multiple-Dose Hydrocodone Extended Release in Healthy Subjects
| العنوان: | Effect of Food on the Pharmacokinetics of Single- and Multiple-Dose Hydrocodone Extended Release in Healthy Subjects |
|---|---|
| المؤلفون: | William Tracewell, Murray P. Ducharme, Mona Darwish, Laura Rabinovich-Guilatt, Sally Selim, Philippe Colucci, Ofer Spiegelstein, Richard Malamut, Ronghua Yang, Mary Bond, Philmore Robertson |
| المصدر: | Clinical Drug Investigation. 37:1153-1163 |
| بيانات النشر: | Springer Science and Business Media LLC, 2017. |
| سنة النشر: | 2017 |
| مصطلحات موضوعية: | Adult, Male, Population, Biological Availability, Pharmacology, 030226 pharmacology & pharmacy, Food-Drug Interactions, 03 medical and health sciences, 0302 clinical medicine, Animal science, Pharmacokinetics, 030202 anesthesiology, Humans, Medicine, Pharmacology (medical), Hydrocodone, Dosing, education, Adverse effect, Morning, education.field_of_study, Cross-Over Studies, business.industry, Fasting, General Medicine, Crossover study, Healthy Volunteers, Naltrexone, Bioavailability, Analgesics, Opioid, Area Under Curve, Delayed-Action Preparations, Female, business, medicine.drug |
| الوصف: | Food intake can alter the pharmacokinetics of certain medications, including changes in their oral bioavailability, which is of particular concern for extended-release (ER) opioids because of the high drug loads. Two randomized, open-label studies assessed the effect of food on the pharmacokinetics of single and multiple doses of hydrocodone ER formulated with CIMA® Abuse-Deterrence Technology. Healthy subjects in fed and fasted states received single 90-mg doses of hydrocodone ER (Studies 1 and 2) or multiple doses of hydrocodone ER (45 mg twice daily on days 2–3, 60 mg twice daily on days 4–5, 90 mg twice daily on days 6–10, and 90 mg once in the morning on day 11) (Study 2). Naltrexone was administered to minimize opioid-related adverse events. Pharmacokinetic parameters included maximum hydrocodone plasma concentration (C max) and area under the concentration-versus-time curve from time 0 to infinity (AUC0–∞) in Study 1 (day 1) and for one dosing interval at steady state (AUCτ,ss) in Study 2 (day 11). Before conducting the multiple-dose study, single-dose data were fitted with a population pharmacokinetic methodology. In total, 40 subjects were randomized to Study 1 and 43 subjects were randomized to Study 2. While overall exposure (AUC0–∞) was relatively similar (least squares mean ratio [90% CI]: 1.11 [1.06–1.16]), results indicated that the single-dose C max was 40% higher under fed versus fasted conditions (least squares mean ratio [90% CI]: 1.40 [1.31–1.51]; Study 1). Modeling of single-dose data predicted that the effect of food would be much less at steady state [predicted fed:fasted C max at steady state (C max,ss) and AUCτ,ss ratios of 1.18 and 1.09, respectively]. The multiple-dose study results validated these predicted ratios and indicated that the steady-state 90% CIs were within 0.80–1.25 for the fed:fasted C max,ss (1.14 [1.07–1.21]) and AUCτ,ss (1.11 [1.04–1.17]) parameters, indicating that clinically meaningful food effects at steady state are not expected. No evidence of an effect of food was found on the pharmacokinetics of hydrocodone ER after multiple days of twice-daily dosing. |
| تدمد: | 1179-1918 1173-2563 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b779fa3f68f71975bab5b4a4aa92933cTest https://doi.org/10.1007/s40261-017-0575-3Test |
| حقوق: | CLOSED |
| رقم الانضمام: | edsair.doi.dedup.....b779fa3f68f71975bab5b4a4aa92933c |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 11791918 11732563 |
|---|